Castor EDC announced raising $6.25M from Inkef
Castor EDC, an Amsterdam, Netherlands health-tech startups, accelerating the medical research process with user-friendly technology, announced that it raised $6.25 million (€5.3M).
This seed funding round was led by INKEF Capital, an Amsterdam based technology, and healthcare venture capital firm, with several angel investors.
“Medical data has become the world’s most valuable asset, yet it wastes away in modern-day research,” Derk Arts, Castor’s founder and CEO, states. “At Castor, we have built a cutting-edge, user-friendly Electronic Data Capture [EDC] platform that we are putting in the hands of every medical researcher worldwide. With the help of our system, we allow researchers to streamline the clinical trial process and use their data to its full potential.”
The platform enables researchers to set up data capture forms, collaborate with colleagues, invite patients through questionnaires, import, export and analyze their data in a secure, compliant cloud environment, all without elaborate training or technical skills.
By helping standardize their data using machine learning, researchers will be able to create the most extensive, most diverse, distributed medical research dataset the world has ever seen. “This would allow the medical community to discover potential cures for diseases much faster,” Arts said.
The funding, which comes on the back of Castor closing its third major deal with a large academic hospital, will be used to expand in the US, and to continue development of its research platform.


Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom